Allergan to acquire medical aesthetics company for $195m

18-09-2018

Allergan to acquire medical aesthetics company for $195m

miodrag ignjatovic / iStockphoto.com

Allergan has revealed plans to buy Bonti, a biotechnology company focused on medical aesthetics, for $195 million.  


Allergan, Bonti, mergers & acquisitions, M&A, neurotoxins, medical aesthetics, Botox,

LSIPR